by Drug and gene delivery involves transporting therapeutic agents like drugs, proteins or DNA to specific targets in the human body to treat diseases and medical conditions. Traditional methods like oral administration or injections often lack efficacy due to degradation or metabolism of the drugs before reaching their target sites. Targeted delivery ensures drugs are protected and released only where needed. This improves therapeutic benefits and reduces side effects.
Nanoparticle-based Delivery Systems
Nanoparticles offer promising solutions for targeted Drug and Gene Delivery Devices. They can encapsulate, protect and carry therapeutic payloads before releasing them intracellularly or in specific organs. Nanoparticles modified with ligands bind to receptors on target cells, facilitating uptake. Popular nanocarriers include liposomes, polymeric nanoparticles and inorganic nanoparticles made of metals. Liposomes are lipid vesicles that mimic cell membranes, allowing drugs to cross cellular barriers. Polymeric nanoparticles protect cargoes through biodegradable polymers like PEG, PLGA and chitosan. Gold and magnetic nanoparticles guide payloads using external stimuli like light or magnetism.
Implantable Drug and Gene Delivery Devices
Implantable devices provide sustained, controlled release of drugs over long periods. Biodegradable polymeric implants made of materials dissolve slowly, releasing drugs at predetermined rates. Some implantable devices use electrochemically controlled reservoirs that are programmed wirelessly to release drugs on demand. Implants targeting the eye use biocompatible polymers to deliver drugs intravitreally for retina diseases. Spinal drug delivery systems use programmable pumps to infuse pain medications directly into the intrathecal space along the spinal cord.
Nanobio hybrid Systems
The integration of nanoparticles with therapeutic devices combines targeted delivery with controlled release capabilities. Some polymeric implants and medical devices are embedded with nanoparticles to facilitate multi-modal therapies. Nanobiohybrid hydrogels combine hydrophilic polymers with drug-loaded nanoparticles to modify drug release profiles. Theranostic nanoparticles integrate diagnostic imaging and therapeutic functions in one system for image-guided treatments. Nanobio hybrid platforms enable modulation of biological responses at molecular levels for personalized therapies.
Gene Delivery Vectors
Drug and gene delivery devices applications employ viral and non-viral vectors to transport corrective genetic material intracellularly. Common viral vectors include adenoviruses, retroviruses high transfection efficiencies but risks of toxicity, immunogenicity and limited cargo sizes. Non-viral systems use cationic polymers, lipids and inorganic nanoparticles. Despite lower efficiencies, they provide safer alternatives. Emerging technologies utilize cell-penetrating peptides, exosomes and extracellular vesicles for enhanced intracellular gene transport with low cytotoxicity. Physical methods like electroporation and sonoporation also improve gene delivery via transient membrane permeabilization.
Current Challenges and Future Prospects
While significant advances have been made, prevalent challenges include enhancing intracellular trafficking, endosomal escape of payloads, cellular targeting and controlled/sustained release. Biocompatibility, safety and immunogenicity issues must also be addressed, especially with repeated administrations. Upcoming innovations involve stimulus/environment-responsive drug and gene delivery devices, multifunctional carriers combining diagnostic/therapeutic features and combinations of physical/chemical/biological modalities. Advances in material sciences, microfabrication, and microfluidics and biomedical engineering techniques will fuel further progress. With expected clinical translations of nucleic acid therapeutics for conditions like cancer and genetic disorders, drug/gene delivery systems hold immense future potential for effective treatments.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
